Skip to content

Effect of Marzanjosh (unani medicine) on Metabolic syndrome

Effect of Marzanjosh (Origanum Vulgare L.) on Metabolic syndrome: A randomized placebo-controlled study

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/06/053618
Enrollment
54
Registered
2023-06-07
Start date
Unknown
Completion date
Unknown
Last updated
2023-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E88- Other and unspecified metabolic disorders

Interventions

Intervention1: Marzanjosh: 6gm of marzanjosh (origanum vulgare) in capsule form in two divided doses per day for 8 weeks Control Intervention1: Placebo: Placebo (wheat flour) 6gm will be given in caps

Sponsors

National Institute of Unani Medicine
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: A)According to NCEP ATP • Criteria Any three of the following 1)Waist circumference >= 90 cm in men and >= 80 cm in females 2)Fasting Plasma Glucose Level >= 100 mg/dl or (diagnosed patient with type 2 Diabetes) 3)HDL level 4)Triglycerides >= 150 mg/dl or (diagnosed patients with dyslipidemia). 5)Blood pressure > 130/85 mmHg, or (diagnosed patient with hypertension)

Exclusion criteria

Exclusion criteria: 1.Pregnant and lactating women 2.Patients having cardiac, liver and renal disorders 3.Patients of secondary obesity 4.Diabetes mellitus requiring the use of insulin. 5.BMI > 35 kg/m2

Design outcomes

Primary

MeasureTime frame
Effect on metabolic control: 1.FBS 2.Waist Circumference 3.Systolic and Diastolic Blood pressure 4.HDL 5.Triglycerides Timepoint: 8 weeks

Secondary

MeasureTime frame
1. Assessment of Quality-of-Life, World Health Organization Quality of life questionnaire (WHOQOL-BREF 2. Body Mass Index (BMI) Timepoint: 8 weeks

Countries

India

Contacts

Public ContactDr Abdul Mobeen

National Institute of unani medicine

dr.mobeen@rediffmail.com7975341778

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026